Biblio Discovery — Demo Discovery Service

1,237 results

Showing 1–20 · 0.39 seconds · RSS

Journal

Molecular Neurodegeneration

Scopus

ISSN 1750-1326 · BMC · 1,237 articles in the index

  1. Journal Article

    Multi-omics insights into GBA1-associated Parkinson’s disease: interplay of genomics, transcriptomics, proteomics, and lipidomics

    Yang Ni; Huaibin Cai; Yaping Shao et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disorder worldwide. The pathogenesis of PD is driven by multifactorial mechanisms involving a complex interplay among environmental exposures, genetic susceptibility, and aging-related processes. Among genetic…

  2. Journal Article

    Developmental dopamine loss rewires striatal circuits to promote locomotion

    Jie Dong; Breanna T. Sullivan; Victor M. Martinez Smith et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Motor symptoms of Parkinson’s disease (PD) primarily result from the degeneration of nigrostriatal dopaminergic neurons (DANs), particularly the Aldehyde Dehydrogenase 1A1-positive (ALDH1A1⁺) subpopulation. Pitx3-deficient mice exhibit selective developmental loss of ALDH1A1⁺…

  3. Journal Article

    OMG! A proteomic determinant of neurodegenerative resiliency

    Michael R. Duggan; Hamilton Se-Hwee Oh; Philipp Frank et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Biofluid proteomics can enhance our understanding of the neurodegenerative mechanisms underlying Alzheimer’s disease and related dementias (ADRDs). Oligodendrocyte myelin glycoprotein (OMG) is a brain-specific protein implicated in myelination, but its potential mechanistic…

  4. Journal Article

    Organelle stress in NLRP3 inflammasome: a central mediator of neurodegenerative diseases

    Huachao Jia; Lianghua Ma; Jinyue Liu et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Organelle stress and NLRP3 inflammasome activation have been established as pivotal contributors to inflammatory responses and play a significant role in the pathogenesis of neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD) and Parkinson’s disease (PD). However, the…

  5. Journal Article

    The molecular fidelity of Aβ pathology in 5xFAD and AppNL−FPsen1P117L mice revealed by cryo-EM

    Meinai Song; Hanrun Zheng; Jianting Han et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Animal models, particularly mouse models, are indispensable for understanding the pathogenic mechanisms and developing therapeutic and diagnostic drugs for Alzheimer’s diseases (AD). While most AD mouse models aim to mimic amyloid-β (Aβ) pathology in their brains, previous research has…

  6. Journal Article

    Systemic complement factors in aging, Alzheimer’s disease and other dementias: a longitudinal study over 10 years

    Xiaofeng Fu; Huimin Cai; Shuiyue Quan et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Complement dysregulation is increasingly recognized in Alzheimer’s disease (AD). However, the temporal profile of complement alterations preceding AD onset and their distinction from age-related immune changes remain poorly defined. Clarifying these dynamics could provide…

  7. Journal Article

    Plasma platelet-derived growth factor receptor-β decrease correlates with blood-brain barrier damage in Alzheimer’s disease

    Jieyin Li; Anqi Li; Chenghui Ye et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background The blood-brain barrier (BBB) damage is frequently observed in Alzheimer’s disease (AD). However, it remains unclear whether plasma platelet-derived growth factor receptor-β (PDGFRβ) level is related to BBB damage and how it correlates with AD core pathologies…

  8. Journal Article

    Tau oligomers modulate synapse fate by eliciting progressive bipartite synapse dysregulation and synapse loss

    Kristeen A. Pareja-Navarro; Christina D. King; Grant Kauwe et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Synapse function is critical for cognition, and synapse loss is highly correlated with cognitive decline in Alzheimer’s disease and related dementias. Tau oligomers, which accumulate in the brain in Alzheimer’s disease, can acutely inhibit synaptic plasticity and cause synapse…

  9. Journal Article

    Impaired nucleocytoplasmic transport in SOD1-mediated ALS

    Shirel Argueti-Ostrovsky; Su Min Lim; Olubankole A. Arogundade et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Impaired nucleocytoplasmic transport (NCT) has emerged as a shared pathogenic mechanism in various neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Although mutations in the gene encoding superoxide dismutase 1 (SOD1) account for approximately 20% of…

  10. Journal Article

    Synaptic control of retinal ganglion cell survival and axon regeneration

    Yuxuan Qiu; Qi Zhang; Jiahui Tang et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Injury to retinal ganglion cell (RGC) axons in neurodegenerative conditions like glaucoma leads to irreversible vision loss. A major therapeutic challenge is promoting RGC survival and axon regeneration. Canonical research focused on intrinsic neuronal growth capacity and the…

  11. Journal Article

    Dynamic [18F]PI-2620 recording facilitates prediction of β-amyloid positivity and simultaneous staging of tau and neurodegeneration

    Johannes Gnörich; Julia Kusche-Palenga; Agnes Kling et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Patients with Alzheimer’s disease (AD) and clinically overlapping neurodegenerative diseases are classified molecularly using the A/T/N classification system. Apart from fluid biomarkers and structural MRI, A/T/N assessment incorporates β-amyloid-PET (A), tau-PET (T), and…

  12. Journal Article

    TDP-43 dysfunction facilitates the pathological conversion of tau

    Meghraj S. Baghel; Grace D. Burns; Margarita Tsapatsis et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract TDP-43 proteinopathy coexists with tauopathy in a variety of neurodegenerative disorders, including Alzheimer’s Disease (AD) and AD related dementia (ADRD). While such co-pathology of TDP-43 is strongly associated with worsened neurodegeneration, the pathogenic mechanism underlying the…

  13. Journal Article

    Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice

    Praveen Bathini; Stephan Schilling; Jens-Ulrich Rahfeld et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Anti-amyloid antibody treatment for Alzheimer’s disease is linked to Amyloid-Related Imaging Abnormalities (ARIA), including vasogenic edema (ARIA-E) and microhemorrhages (ARIA-H), especially in ApoE ε4/4 carriers. To investigate mechanisms underlying ARIA, we examined the binding and…

  14. Journal Article

    Plasma proteomic signatures of preclinical Alzheimer’s disease in clinically unimpaired older adults

    Alexandra N. Trelle; Karly A. Cody; Tran T. Nguyen et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Multi-analyte plasma proteomic panels that can accurately detect initial Alzheimer’s disease (AD) pathology in preclinical populations and simultaneously measure related biological processes relevant for disease risk are critical for advancing early detection and prognosis…

  15. Journal Article

    Pharmacological restoration of impaired autophagy in retinal ganglion cells prevents abnormal mitochondrial accumulation and glaucomatous neurodegeneration

    Prabhavathi Maddineni; Balasankara Reddy Kaipa; Bindu Kodati et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Progressive loss of retinal ganglion cells (RGCs) and degeneration of optic nerve (ON) axons are the key pathological hallmarks of glaucoma, the leading cause of irreversible blindness. Elevated intraocular pressure (IOP), primarily due to dysfunction of the trabecular meshwork…

  16. Journal Article

    Dual orexin receptor antagonism with lemborexant enhances microglial clearance of β-amyloid in mice

    Ashish Sharma; Emiko Segawa; Xiaoying Chen et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Sleep disturbances elevate brain amyloid-beta (Aβ) levels and represent a modifiable risk factor for Alzheimer’s disease (AD). The orexin/hypocretin system regulates sleep–wake behavior and has emerged as a therapeutic target in AD; however, the effects of FDA-approved dual…

  17. Journal Article

    LRRK2 and GBA1 in Lewy body diseases: neuropathological subtypes at opposite ends of a spectrum?

    Vedika Jha; Lorraine V. Kalia

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Lewy body diseases (LBDs), including Parkinson’s disease (PD), are defined by the presence of pathological intraneuronal α-synuclein aggregates but exhibit considerable heterogeneity in clinical course, neuropathology, and underlying mechanisms. This review summarizes neuropathological…

  18. Journal Article

    A reappraisal of APOE genetic effects on Alzheimer’s disease risk in the Japanese population: a meta-analysis

    Akinori Miyashita; Norikazu Hara; Ai Obinata et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Our meta-analysis demonstrates that the risk effect of APOE-e4*4 relative to APOE-e3*3 for Alzheimer’s disease in the Japanese population is approximately 12–15-fold, comparable to that reported in Caucasian populations, rather than greater than 20-fold as previously reported.

  19. Journal Article

    Retromer-targeted therapy for neurodegenerative diseases

    Michele Persico; Sophronea Tuithung; Alejandra Lorenzo et al.

    Molecular Neurodegeneration, Vol. 21 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Alzheimer’s disease (AD), Parkinson’s disease (PD), and Amyotrophic Lateral Sclerosis (ALS) are neurodegenerative diseases characterized by dysfunction of the endosomal-lysosomal system (ELS). Four shared neurodegenerative mechanisms across ALS, PD and AD are regulated by the ELS, namely…

Showing at most 50 pages. Narrow your search with filters for more specific results.